Thieler Law Corp advises investors with losses exceeding $100,000 of the May 29, 2018 lead plaintiff deadline in a class action lawsuit filed against Solid Biosciences Inc (NASDAQ: SLDB) (“Solid Biosciences” or “the Company”). The suit is pending in the U.S. District Court for the District of Massachusetts and investors, who purchased Solid Biosciences Inc securities between January 25, 2018 and March 14, 2018, have until May 29, 2018 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Solid Biosciences Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Solid Biosciences’ lead drug candidate SGT-001 had a high likelihood of causing adverse events in patients; that Solid Biosciences misled investors regarding the toxicity of SGT-001; and that, as a result of the foregoing, Defendants statements in the Registration Statement regarding Solid Biosciences’ business, operations, and prospects, were materially false and/or misleading.

On March 14, 2018, Solid Biosciences issued a press release revealing receipt of a “notification from the U.S. Food and Drug Administration that IGNITE DMD, its Phase I/II clinical trial for SGT-001 microdystrophin gene transfer in Duchenne muscular dystrophy (DMD), has been placed on Clinical Hold.”

Following this news, NASDAQ: SLDB fell $16.99 per share, or over 64%, to close at $9.32 on March 15, 2018.

If you were negatively impacted by your investment in Solid Biosciences Inc securities between January 25, 2018 and March 14, 2018 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185